NASDAQ:APRI
Delisted

Apricus Biosciences Fund Signals

$1.03
+0 (+0%)
At Close: May 27, 2022

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $1.03 0 %
High/ Low $1.03 - $1.03 0%
Chg 7 Days N/A $1.03 $1.03
Chg 30 Days N/A $1.03 $1.03
Chg 12 mos -68.50 % $3.27 $1.03
Trend - 3 mos -0.260 % Width: 2.92 %
Trend - 12 mos -62.75 % Width: 64,318.55 %
Pred. range - 3 mos $1.02 - $1.05 -0.520 % - 2.38 %
Pred. range - 12 mos $0.0007 - $0.483 -99.93 % - -53.16 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2022-02-16 - 71 days
Long MA avg 12 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Buy 2022-03-01 - 63 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Apricus Biosciences

Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The company’s marketing partners for Vitaros include Laboratoires Majorelle, Bracco S.p.A., Hexal AG (Sandoz), Takeda Pharmaceuticals Int... APRI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT